Novartis gets USFDA nod for its therapy to treat Berger’s disease – Healthcare News
Novartis on Thursday announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia (atrasentan) to treat...
Novartis on Thursday announced the US Food and Drug Administration (FDA) has granted accelerated approval for Vanrafia (atrasentan) to treat...
Novartis has recently announced that its intrathecal (IT) formulation of onasemnogene abeparvovec (OAV101 IT) successfully achieved the primary endpoint in...
Novartis on Wednesday announced that the European Commission (EC) has approved Kisqali (ribociclib) for the treatment of early breast cancer...